Stromelysin-2

BE0003689ProteinHumansMMP10

Can degrade fibronectin, gelatins of type I, III, IV, and V; weakly collagens III, IV, and V. It is acted on by 2 drugs in DrugBank.

Gene name
MMP10
UniProtKB entry
P09238Swiss-Prot
Cellular location
Secreted, extracellular space, extracellular matrix
Residues / weight
476 residues · 54,151 Da
Also known as
3.4.24.22 · Matrix metalloproteinase-10 · MMP-10 · SL-2 · STMY2

Resolves to

Protein
UniProtP09238UniProt nameMMP10_HUMAN
Gene
HGNCHGNC:7156NCBI Gene4319GenBank36629GeneCardsMMP10
Pharmacology
IUPHAR/GtoPdb1634KEGGhsa:4319
Structure
PDB1Q3APDB3V96PDB4ILW
Drugs

What you can answer from here — as of September 07, 2019

2DrugsApproved to experimental, with action, bond type and pharmacological action
Sign in
2GO termsFunction, process and component, as structured annotations
Sign in
3Pfam domainsDomain architecture mapped to Pfam families and clans
Sign in
8+ReferencesStructured and connected to the statements they support
Sign in

Which compounds in development act on Stromelysin-2, and which indications are they being tested in?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In